Amarin Corp. Plc (AMRN)
14.20
+0.27
(+1.94%)
USD |
NASDAQ |
Jun 08, 15:50
Amarin EPS Diluted (Quarterly) : -0.501 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Akari Therapeutics Plc | -9.584 |
| Cellectis SA | -0.1774 |
| Agenus, Inc. | 1.023 |
| Grifols SA | 0.1255 |
| Trinity Biotech Plc | -0.9375 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.49M |
| Revenue (Quarterly) | 45.06M |
| Total Expenses (Quarterly) | 55.55M |
| Enterprise Value | -10.19M |
| Gross Profit Margin (Quarterly) | 37.96% |
| Profit Margin (Quarterly) | -23.29% |
| Earnings Yield | -11.41% |
| Normalized Earnings Yield | -1.971 |